Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Gene Therapy
Research from Shaanxi Normal University, College of Life Sciences provides new data on gene therapy
April 10th, 2007
Current study results from the report, "Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors," have been published. "RNA interference (RNAi) mediated by double-stranded small interfering RNA (siRNA) is a novel mechanism of sequence-specific, post-transcriptional gene silencing. There has been much research into the use of RNAi for the treatment of human diseases," scientists writing in the International Journal of Molecular Medicine report. "Many viruses, including hepatitis B virus (HBV), are susceptible to inhibition by this mechanism. However, for RNAi to be efficacious therapeutically,...
Source: Virus Weekly (2007-04-10)
|
